AbbVie

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AbbVie and other ETFs, options, and stocks.

About ABBV

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions.

CEO

Richard A. Gonzalez

CEORichard A. Gonzalez

Employees

50,000

Employees50,000

Headquarters

North Chicago, Illinois

HeadquartersNorth Chicago, Illinois

Founded

2011

Founded2011

Employees

50,000

Employees50,000

ABBV Key Statistics

Market cap

250.61B

Market cap250.61B

Price-Earnings ratio

19.98

Price-Earnings ratio19.98

Dividend yield

3.92

Dividend yield3.92

Average volume

6.28M

Average volume6.28M

High today

$145.53

High today$145.53

Low today

$141.29

Low today$141.29

Open price

$142.40

Open price$142.40

Volume

5.59M

Volume5.59M

52 Week high

$175.91

52 Week high$175.91

52 Week low

$106.86

52 Week low$106.86

ABBV News

Simply Wall St 4d

AbbVie Inc.'s Business Is Trailing The Market But Its Shares Aren't - Yahoo Finance

With a price-to-earnings (or "P/E") ratio of 20.1x AbbVie Inc. (NYSE:ABBV) may be sending bearish signals at the moment, given that almost half of all companies...

Analyst ratings

58%

of 24 ratings

Buy

58.3%

Hold

37.5%

Sell

4.2%

ABBV Earnings

$0.00

$1.12

$2.25

$3.37

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Oct 28, Pre-Market

ActualExpected Oct 28, Pre-Market